| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.082 | 0.005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.006 |